Research paperSingle-nucleotide polymorphisms (rs342275, rs342293, rs7694379, rs11789898, and rs17824620) showed significant association with LOBAPLATIN (cas 135558-11-1)-induced thrombocytopenia

Add time:08/15/2019    Source:sciencedirect.com

This study aimed to investigate single-nucleotide polymorphisms (SNPs) associated with lobaplatin-induced thrombocytopenia in patients with advanced lung cancer in China. Thirty-nine patients who received lobaplatin-based chemotherapy in the 307 Hospitals of Chinese People's Liberation Army from April 2017 to March 2018 were enrolled as study subjects. Peripheral blood DNA was extracted, and 79 candidate SNP positions were selected. A Sanger sequencing platform was employed to measure genotypes for locating the SNP positions associated with lobaplatin-induced thrombocytopenia. Of the 79 candidate genes, SNPs rs342275 and rs7694379 were significantly associated with lobaplatin-induced decrease in platelet (PLT) count (P < 0.05). SNPs rs342275, rs342293, rs11789898, and rs17824620 showed significant association with lobaplatin-induced lowest PLT counts (P < 0.05). SNPs rs342275, rs342293, rs11789898, rs17824620, and rs7694379 can be used as predictors of thrombocytopenia induced by lobaplatin-based chemotherapy in patients with advanced lung cancer in China.

We also recommend Trading Suppliers and Manufacturers of LOBAPLATIN (cas 135558-11-1). Pls Click Website Link as below: cas 135558-11-1 suppliers

Prev:LOBAPLATIN (cas 135558-11-1) suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model
Next:Original articleLOBAPLATIN (cas 135558-11-1)-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment)